ClearPlasma is a first-in-class medical device that removes plasminogen from donor plasma just before transfusion, improving clotting efficiency and reducing bleeding. Proven in three clinical trials, it enables up to 45% fewer plasma units and 2.2 fewer platelet units per patient, shortening hospitalization. Easy to use with no extra training, ClearPlasma is already approved in Israel and Ukraine and supported by the U.S. Department of Defense